SIG
GILD icon

Stanford Investment Group’s Gilead Sciences GILD Stock Holding History

Stanford Investment Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2,409
Closed -$173K – 109
2016
Q4 		$173K Sell
2,409
-310
-11% -$23K 0.08% 58
2016
Q3 		$215K Buy
2,719
+110
+4% +$8.94K 0.1% 52
2016
Q2 		$218K Sell
2,609
-23
-0.9% -$2.04K 0.11% 51
2016
Q1 		$242K Sell
2,632
-595
-18% -$53.7K 0.14% 48
2015
Q4 		$327K Buy
3,227
+460
+17% +$47.9K 0.18% 41
2015
Q3 		$272K Sell
2,767
-112
-4% -$12.4K 0.2% 41
2015
Q2 		$337K Sell
2,879
-307
-10% -$33.5K 0.25% 35
2015
Q1 		$313K Buy
3,186
+400
+14% +$40.6K 0.25% 33
2014
Q4 		$263K Buy
+2,786
New +$288K 0.22% 39

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Stanford Investment Group's GILD Position: Q1 2017 in Review

Stanford Investment Group sold out of Gilead Sciences (GILD) in Q1 2017, closing a stake of 2,409 shares — an estimated $173K sold.

Stanford Investment Group first reported a position in GILD in Q4 2014 and held it in 9 quarters. The position peaked at $337K in Q2 2015. 1,525 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

  • Stanford Investment Group reported no remaining Gilead Sciences position as of Q1 2017 after selling out during the quarter.
  • Stanford Investment Group sold 2,409 Gilead Sciences shares in Q1 2017, an estimated $173K.
  • Stanford Investment Group first reported a position in Gilead Sciences in Q4 2014 and held it in 9 quarters.
  • Stanford Investment Group's Gilead Sciences position peaked at $337K in Q2 2015.
  • 1,525 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on Stanford Investment Group's 13F filing for Q1 2017.